CHRONIC USE OF PROTON PUMP INHIBITORS IS ASSOCIATED WITH AN INCREASED RISK OF IMMUNE CHECKPOINT INHIBITOR COLITIS IN RENAL CELL CARCINOMA

被引：0
|
作者：
Yin, Jianyi
Elias, Roy
Peng, Lan
Levonyak, Nicholas
Asokan, Annapoorani
Christie, Alana
Kubiliun, Nisa
Brugarolas, James
Hammers, Hans
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1248
引用
收藏
页码：S560 / S561
页数：2
相关论文
共 50 条
  • [21] Proton pump inhibitor use is associated with an increased risk of severe community acquired infections
    Targownik, Laura E.
    Laheij, Robert J.
    Metge, Colleen
    Leung, Stella
    GASTROENTEROLOGY, 2007, 132 (04) : A159 - A159
  • [22] Concomitant use of clopidogrel and proton pump inhibitors is not associated with an increased risk of coronary events
    Garcia Rodriguez, L. A.
    Cea-Soriano, L.
    Johansson, S.
    EUROPEAN HEART JOURNAL, 2011, 32 : 415 - 415
  • [23] Risk of pneumonia associated with proton pump inhibitor use
    Kenta Watanabe
    Katsunori Iijima
    Journal of Gastroenterology, 2023, 58 : 945 - 946
  • [24] Proton pump inhibitors are not associated with an increased risk of colorectal cancer
    Kuiper, Josephina G.
    Van Herk-Sukel, Myrthe P. P.
    Lemmens, Valery E. P. P.
    Kuipers, Ernst J.
    Herings, Ron M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 568 - 568
  • [25] Proton pump inhibitors are not associated with an increased risk of hepatic encephalopathy
    Gairing, Simon Johannes
    Mangini, Chiara
    Zarantonello, Lisa
    Nielsen, Elise Jonasson
    Dobbermann, Henrike
    Sultanik, Philippe
    Galle, Peter R.
    Labenz, Joachim
    Thabut, Dominique
    Marquardt, Jens U.
    Bloom, Patricia
    Lauridsen, Mette
    Montagnese, Sara
    Labenz, Christian
    JOURNAL OF HEPATOLOGY, 2024, 80 : S211 - S211
  • [26] Risk of pneumonia associated with proton pump inhibitor use
    Watanabe, Kenta
    Iijima, Katsunori
    JOURNAL OF GASTROENTEROLOGY, 2023, 58 (09) : 945 - 946
  • [27] Proton pump inhibitor use is associated with increased liver steatosis
    Yu, Hongsheng
    Li, Mingkai
    Yang, Bilan
    Sun, Huiying
    Jiang, Hao
    Liang, Zixi
    Smayi, Abdukyamu
    Wu, Bin
    Yang, Yidong
    BIOMEDICAL REPORTS, 2024, 21 (02)
  • [28] The Correlation between the Use of the Proton Pump Inhibitor and the Clinical Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Hu, Da-Hai
    Wong, Wan-Ching
    Zhou, Jia-Xin
    Luo, Ji
    Cai, Song-Wang
    Zhou, Hong
    Tang, Hui
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [29] CHRONIC PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH AN INCREASED RISK OF VASCULAR CALCIFICATIONS IN CHRONIC KIDNEY DISEASE
    Fusaro, Maria
    Fusaro, Maria
    Noale, Marianna
    Tripepi, Giovanni
    D'angelo, Angela
    Miozzo, Davide
    Gallieni, Maurizio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 227 - 227
  • [30] Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Gao, Xin
    McDermott, David F.
    CANCER JOURNAL, 2018, 24 (04): : 171 - 179
12345